Clinical Trials for Lexeo Therapeutics

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Lexeo Therapeutics

Clinical Trials (6)

NCT06865482
Clinical Course Of Disease In Participants With FA-CM
N/ARecruiting
65 participants
Started: Sep 30, 2025 · Completed: Sep 30, 2027
2 conditions1 sponsor4 locations
NCT07050160
Long-term Follow-up Study of Gene Therapy for Arrhythmogenic Cardiomyopathy Due to a Plakophilin-2 Pathogenic Variant
N/ANot yet recruiting
10 participants
Started: Aug 31, 2025 · Completed: Aug 31, 2030
3 conditions1 sponsor0 locations
NCT06109181
Gene Therapy for ACM Due to a PKP2 Pathogenic Variant
PHASE1/PHASE2Recruiting
10 participants
Started: Feb 29, 2024 · Completed: Feb 28, 2027
3 conditions1 sponsor5 locations
NCT06976606
A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM
N/ARecruiting
40 participants
Started: Jan 23, 2024 · Completed: Sep 30, 2027
3 conditions1 sponsor6 locations
NCT05400330
Long-Term Follow-up of Gene Therapy for APOE4 Homozygote Alzheimer's Disease
PHASE1Active, not recruiting
10 participants
Started: May 8, 2023 · Completed: Nov 30, 2028
1 condition1 sponsor2 locations
NCT05445323
Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia
PHASE1/PHASE2Active, not recruiting
8 participants
Started: Aug 24, 2022 · Completed: Sep 30, 2029
2 conditions1 sponsor3 locations